GlassScriptPhysician profile
Cynthia Hildebrand
NPI 1083665376
$8,376.63
in general payments reported to CMS, 2019-2025
42 companies · $112 in 2025
The $112 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,255 · 2022: $2,022 · 2023: $2,274 · 2024: $1,714 · 2025: $112.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,100.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,100.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,887.34 | 2021-2025 | |
| Amgen INC. | $845.24 | 2021-2024 | Evenity, Prolia, Repatha |
| Astrazeneca Pharmaceuticals LP | $527.02 | 2021-2024 | Airsupra, Fasenra |
| Pfizer INC. | $521.09 | 2021-2024 | |
| Novo Nordisk INC | $495.75 | 2021-2024 | Rybelsus, Ozempic, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $414.08 | 2021-2024 | Jardiance |
| Janssen Pharmaceuticals, INC | $356.48 | 2021-2024 | Xarelto |
| Lilly USA, LLC | $321.50 | 2021-2024 | Mounjaro, Zepbound, Jardiance |
| Glaxosmithkline, LLC. | $308.81 | 2021-2024 | Trelegy Ellipta, Shingrix, Arexvy |
| Bayer Healthcare Pharmaceuticals INC. | $284.15 | 2021-2024 | |
| Novartis Pharmaceuticals Corporation | $255.39 | 2022-2024 | |
| Eisai INC. | $217.04 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $206.35 | 2021-2024 | Vaxelis, Gardasil, Gardasil 9 |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $147.57 | 2022-2024 | Caplyta |
| Astellas Pharma US INC | $146.28 | 2021-2024 | Veozah |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cynthia Hildebrand listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.